Start free

ProMIS Neurosciences Inc. (PMN) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 6, 2026.

Filings shown
14
Open-market buys
4
Open-market sells
0
Buys, 10b5-1 box not checked
4 of 4

Counts cover the 14 most recent Form 4 filings Tradune holds for PMN (filed May 22 – Nov 6, 2026); the score below covers only the trailing 90 days (3 buys, 0 sells). SEC EDGAR Form 4 filings for PMN last checked Nov 17, 2026, 09:01 UTC; the latest PMN filing Tradune holds was filed Nov 6, 2026. This is not guaranteed to be the complete record — see PMN's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 4 filings Tradune holds for PMN filed Oct 6 – Nov 6, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Eugene WilliamsDirector 2 0 27,816 — +$96,146
Neil CashmanChief Scientific Officer 1 0 10,000 — +$38,600

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

78/ 100

Purchase cluster incl. officer
2 distinct buyers3 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

PMN appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Nov 10, 2026
    2 insiders buying · $134,746 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at PMN

Insiders reported 4 open-market purchases of PMN between May 22, 2026 and Nov 6, 2026, across 3 distinct buyers. The most recent purchase was reported by Eugene Williams (Director) on Nov 4, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Eugene Williams Director · filed Nov 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 26,500 $3.43 40,213 +193% Nov 4, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Neil Cashman Chief Scientific Officer · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,000 $3.86 14,532 +221% Nov 2, 2026
Eugene Williams Director · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,316 $3.99 13,713 +11% Oct 30, 2026
Ivana Rubino Chief Commercial Officer · filed Oct 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 80,000 — — — Oct 5, 2026
Johanne Kaplan Chief Development Officer · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,280 $13.30 6,221 +58% Aug 5, 2026
William W. Wyman Director · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 5,500 — — — May 20, 2026
Grant / award Option (right to buy) 11,000 — — — May 20, 2026
Eugene Williams Director · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 5,500 — — — May 20, 2026
Grant / award Option (right to buy) 11,000 — — — May 20, 2026
Neil K. Warma Chief Executive Officer · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 160,000 — — — May 20, 2026
Madge K. Shafmaster Director · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 5,500 — — — May 20, 2026
Grant / award Option (right to buy) 11,000 — — — May 20, 2026
Neil Cashman Chief Scientific Officer · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 50,000 — — — May 20, 2026
Max A. Milbury Principal Accounting Officer · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 18,167 — — — May 20, 2026
Josh Mandel-Brehm Director · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 11,000 — — — May 20, 2026
Grant / award Option (right to buy) 5,500 — — — May 20, 2026
Johanne Kaplan Chief Development Officer · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 50,000 — — — May 20, 2026
Slanix Paul Alex Director · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Option (right to buy) 11,000 — — — May 20, 2026
Grant / award Option (right to buy) 5,500 — — — May 20, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to PMN's (Nov 6, 2026).

Frequently asked about PMN insider activity

How many insiders bought PMN stock in these Form 4 filings?

3 distinct insiders at ProMIS Neurosciences Inc. reported 4 open-market purchases (Form 4 code P) of PMN shares between May 22, 2026 and Nov 6, 2026, the most recent filed by Eugene Williams (Director) on Nov 4, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for PMN?

The most recent Form 4 on this page was filed by Eugene Williams (Director) on Nov 6, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market PMN insider purchase shown?

The largest open-market purchase among the filings shown was 26,500 PMN shares at $3.43 (about $90,895) by Eugene Williams (Director) on Nov 4, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent PMN insider purchases have the Form 4 10b5-1 box checked?

No. All 4 PMN open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Eugene Williams (Director) on Nov 4, 2026, 26,500 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for PMN — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.